ANI Pharmaceuticals ANIP Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's accrued manufacturing costs?
- ANI Pharmaceuticals (ANIP) reported accrued manufacturing costs of $16.09M in Q1 2026.
- How has ANI Pharmaceuticals's accrued manufacturing costs changed year-over-year?
- ANI Pharmaceuticals's accrued manufacturing costs decreased by 27.8% year-over-year, from $22.3M to $16.09M.
- What is the long-term trend for ANI Pharmaceuticals's accrued manufacturing costs?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's accrued manufacturing costs has grown at a 43.5% compound annual growth rate (CAGR), from $6.23M to $37.9M.